HAEMONETICS CORP shareholders Q3 2023

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
BEACON INVESTMENT ADVISORS LLC 12,057$1,080,0660.76%
Virtus Fund Advisers, LLC 1,186$106,2420.75%
OBERWEIS ASSET MANAGEMENT INC/ 77,400$6,933,4920.74%
Arjuna Capital 21,004$1,881,5390.67%
EMERALD ADVISERS, LLC 151,463$13,568,0270.66%
Cinctive Capital Management LP 139,388$12,486,3770.62%
Keene & Associates, Inc. 8,512$762,5050.61%
EMERALD MUTUAL FUND ADVISERS TRUST 109,636$9,821,1930.59%
Boston Trust Walden Corp 720,529$64,544,9880.54%
SCHWARTZ INVESTMENT COUNSEL INC 119,000$10,660,0200.46%
External links

This page lists HAEMONETICS CORP's shareholders in Q3 2023. To view HAEMONETICS CORP's shareholder history, click here.